18 King Street East
Suite 1400
Toronto, ON M5C 1C4
Canada
833-285-2666
https://www.nugenmd.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Anthony Di Benedetto | Executive Chairman | 99,79k | N/A | 1972 |
Mr. Ian Heynen | Chief Executive Officer | 49,5k | N/A | N/A |
Mr. Richard Buzbuzian BA | President & Director | 209,55k | N/A | 1971 |
Ms. Veronique Laberge B.A., CPA | CFO & Secretary | 121,74k | 64,86k | 1983 |
Mr. Nicky Canton | Executive VP & COO | 141,01k | N/A | 1984 |
Ms. Karen Dunlap | Interim Chief Customer Officer & Director | 95k | N/A | 1948 |
Ms. Elisha Dillon | Head of Global Sales & Strategic Partnerships | N/A | N/A | N/A |
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
NuGen Medical Devices Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.